<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9422759</journal-id><journal-id journal-id-type="pubmed-jr-id">2553</journal-id><journal-id journal-id-type="nlm-ta">Occup Environ Med</journal-id><journal-id journal-id-type="iso-abbrev">Occup Environ Med</journal-id><journal-title-group><journal-title>Occupational and environmental medicine</journal-title></journal-title-group><issn pub-type="ppub">1351-0711</issn><issn pub-type="epub">1470-7926</issn></journal-meta><article-meta><article-id pub-id-type="pmid">33139344</article-id><article-id pub-id-type="pmc">10010928</article-id><article-id pub-id-type="doi">10.1136/oemed-2020-106612</article-id><article-id pub-id-type="manuscript">EPAPA1871289</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Urinary mutagenicity and oxidative status of wildland firefighters working at prescribed burns in a Midwestern US forest</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Chieh-Ming</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Warren</surname><given-names>Sarah H</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>DeMarini</surname><given-names>David M</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Chi (Chuck)</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9850-4028</contrib-id><name><surname>Adetona</surname><given-names>Olorunfemi</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>College of Public Health, Division of Environmental Health Sciences, The Ohio State University, Columbus, Ohio, USA</aff><aff id="A2"><label>2</label>Biomolecular and Computational Toxicology Division, United States Environmental Protection Agency, Research Triangle Park, North Carolina, USA</aff><aff id="A3"><label>3</label>College of Public Health, Division of Biostatistics, The Ohio State University, Columbus, Ohio, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><bold>Contributors</bold> OA and C-MW obtained research funding, designed the study, recruited wildland firefighters and collected spot urine samples. C-MW also performed biochemical and statistical analyses with the advice from OA and CS. DMD and SHW performed urinary mutagenicity using the <italic toggle="yes">Salmonella</italic> (Ames) mutagenicity assay. The final manuscript was prepared by C-MW and critically revised by the coauthors.</p></fn><corresp id="CR1"><bold>Correspondence to</bold> Dr Olorunfemi Adetona, College of Public Health, The Ohio, State University, Columbus, OH 43210, USA, <email>adetona.1@osu.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>8</day><month>3</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>02</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>3</month><year>2023</year></pub-date><elocation-id>oemed-2020-106612</elocation-id><abstract id="ABS1"><sec id="S1"><title>Objective</title><p id="P2">Wildland firefighters (WLFFs) experience repeated exposures to wildland fire smoke (WFS).</p><p id="P3">However, studies about WLFFs remain regionally limited. The objective of this study was to assess the effect of WFS exposure on urinary mutagenicity and cell oxidation among WLFFs who work at prescribed burns in the Midwestern USA.</p></sec><sec id="S2"><title>Methods</title><p id="P4">A total of 120 spot urine samples was collected from 19 firefighters right before (pre-shift), immediately after (post-shift), and the morning (next-morning) following work shifts on prescribed burn days (burn days) and regular workdays (non-burn days). The levels of urinary mutagenicity, 8-isoprostane, malondialdehyde and oxidised guanine species (Ox-GS) were measured. Linear mixed-effect models were used to determine the difference of cross-shift changes in the concentrations of urinary biomarkers.</p></sec><sec id="S3"><title>Results</title><p id="P5">Post-shift levels of creatinine-corrected urinary mutagenicity and 8-isoprostane were non-significantly higher than pre-shift levels (1.16&#x000d7; and 1.64&#x000d7;; p=0.09 and 0.07) on burn days. Creatinine-corrected Ox-GS levels increased significantly in next-morning samples following WFS exposure (1.62&#x000d7;, p=0.03). A significant difference in cross-shift changes between burn and non-burn days was observed in 8-isoprostane (2.64&#x000d7;, p=0.03) and Ox-GS (3.00&#x000d7;, p=0.02). WLFFs who contained the fire (performed holding tasks) had a higher pre-morning to next-morning change in urinary mutagenicity compared with those who were lighting fires during the prescribed burns (1.56&#x000d7;, p=0.03).</p></sec><sec id="S4"><title>Conclusions</title><p id="P6">Compared with the other regions, WLFFs who worked in Midwestern forests had an elevated urinary mutagenicity and systemic oxidative changes associated with WFS exposure at prescribed burns.</p></sec></abstract></article-meta></front><body><sec id="S5"><title>INTRODUCTION</title><p id="P7">Health impacts of wildland fire emissions have become a major public health concern. Wildland fire smoke (WFS) is a heterogeneous mixture of air pollutants in the gaseous and particle phases, including carbon monoxide, volatile organic compounds, particulate matter (PM), black carbon (BC) and polycyclic aromatic hydrocarbons (PAHs).<sup><xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R4" ref-type="bibr">4</xref></sup> Wildland firefighters (WLFFs), who are the first defence against wildland fires, are exposed directly and consistently to WFS. Their occupational exposures are exacerbated by extended work hours without appropriate respiratory protection while performing physically demanding activities.<sup><xref rid="R2" ref-type="bibr">2</xref></sup></p><p id="P8">Systemic exposure to the complex mixture of mutagens in biomass smoke can be assessed by measuring urinary mutagenicity.<sup><xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref></sup> Although specific mutagens cannot be identified, urinary mutagenicity has the advantage of non-invasively measuring an integrated level of mutagenic activity without prior knowledge about the mutagens.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Previous epidemiological studies have found increased urinary mutagenicity levels among charcoal workers and wood-fired steam bath users.<sup><xref rid="R7" ref-type="bibr">7</xref>
<xref rid="R8" ref-type="bibr">8</xref></sup> A significant positive association was observed between structural fire smoke exposure and increased urinary mutagenicity in municipal firefighters.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Increased urinary mutagenicity was also observed after WFS exposure among WLFFs in Southeastern USA.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> However, the mutagenic potencies and mutagenicity emission factors vary among different types of biomass emissions.<sup><xref rid="R14" ref-type="bibr">14</xref></sup> Thus, urinary mutagenicity and other systemic effects of WFS may vary due to the different types of biomass fuel in different regions.</p><p id="P9">PM from biomass emissions is composed of PAHs, other mutagenic organics and reactive oxygen species (ROS) that can induce oxidative stress.<sup><xref rid="R2" ref-type="bibr">2</xref>
<xref rid="R3" ref-type="bibr">3</xref>
<xref rid="R15" ref-type="bibr">15</xref></sup> Acute redox activities can be assessed by changes in the levels of urinary oxidative biomarkers including 8-iso-prostaglandin F2&#x003b1; (8-isoprostane), malondialdehyde (MDA) and oxidised guanine species (Ox-GS), that is, 8-hydroxy-2&#x02019;-deoxyguanosine (8-OHdG), 8-hydroxyguanosine (8-OHG) and 8-hydroxyguanine (8-OHGua). 8-Isoprostane and MDA are generated by cellular lipid peroxidation, whereas Ox-GS are formed during repair of oxidised DNA.<sup><xref rid="R6" ref-type="bibr">6</xref>
<xref rid="R16" ref-type="bibr">16</xref>
<xref rid="R17" ref-type="bibr">17</xref></sup> These biomarkers have been used to assess systemic oxidative status resulting from exposure to biomass smoke.<sup><xref rid="R18" ref-type="bibr">18</xref>&#x02013;<xref rid="R22" ref-type="bibr">22</xref></sup></p><p id="P10">To characterise occupational WFS exposure and assess potential health effects on WLFFs working in Midwestern USA, we examined cross-shift changes in the levels of mutagenicity and oxidative biomarkers in spot urine samples collected from WLFFs in Ohio.</p></sec><sec id="S6"><title>MATERIALS AND METHODS</title><sec id="S7"><title>Study location and WLFFs</title><p id="P11">Between 2015 and 2018, a convenience sample of 19 healthy firefighters (17 men and 2 women) were recruited from the US Forest Service&#x02013;Wayne National Forest (USFS-WNF). A baseline questionnaire was provided to each firefighter to obtain information about demography and work history, and two questionnaires were administered to collect self-evaluated WFS exposure and information about daily work activities and potentially confounding exposures immediately after and the morning following each prescribed burn or regular work shift.</p><p id="P12">Prescribed (or controlled) burn is a land management tool used to reduce vegetative fuel load on the forest floor. WLFFs working at prescribed burn are generally involved in two tasks: lighting and/or holding. Firefighters assigned to lighting use a drip torch to ignite fires in predesignated area, whereas those holding, patrol and quench fires at the boundaries to maintain fires within the preplanned burn areas. Prescribed burns are conducted at the USFS-WNF in early spring and late fall. WLFFs on burn days were involved in arduous tasks including lighting and/or holding, whereas they worked at the forest office on non-burn with few exceptions doing fire response training, field investigation and timber management that require less physical exertion compared with the burn day tasks.</p></sec><sec id="S8"><title>Sample collection and exposure assessment</title><p id="P13">Spot (single) urine samples were collected from each firefighter right before (pre-shift, ~20 min before), immediately after (post-shift, ~20 min after), and the morning following (next morning, 12&#x02013;15 hours after) prescribed burn (burn day) and regular (non-burn day) work shifts using 90 mL polypropylene containers. The volume of sample collected from the firefighters was 60&#x02013;70 mL. An aliquot of 25&#x02013;30 mL was used for analysis of urinary mutagenicity and the remaining (30&#x02013;35 mL) raw urine was used for the analyses of oxidative stress biomarkers. The samples were stored immediately after collection in light-proof containers with dry ice and subsequently transported to The Ohio State University. The samples were aliquoted, labelled to ensure confidentiality and stored at &#x02212;80&#x000b0;C until analysis.</p><p id="P14">Personal exposure to PM<sub>2.5</sub> during prescribed burns was measured by gravimetry in the breathing zone of the firefighters using the MicroPEM aerosol sensor (RTI International, Research Triangle Park, North Carolina, USA). The concentration of BC in WFS particulates was determined using a SootScan Model OT21 Optical Transmissometer (Magee Scientific, Berkeley, California, USA). To estimate the organic carbon (OC) content in WFS particulates, a linear relationship (OC=0.567&#x000d7;(PM&#x02212;BC)&#x02212;0.119, r<sup>2</sup>=0.885) derived from a previous study investigating BC emissions from wood-fueled cookstoves was used.<sup><xref rid="R23" ref-type="bibr">23</xref></sup></p></sec><sec id="S9"><title>Urinary mutagenicity and oxidative biomarkers</title><p id="P15">Urinary mutagenicity was assessed as described previously.<sup><xref rid="R5" ref-type="bibr">5</xref>
<xref rid="R8" ref-type="bibr">8</xref></sup> Briefly, ~25 mL of urine was filtered and enzymatically de-conjugated in 0.2 M (10% v/v) sodium acetate buffer (pH 5.0) (Sigma, St. Louis, Missouri, USA), containing &#x003b2;-glucuronidase (6 U/mL urine; Cat. No. G-7017, Sigma, St. Louis, Missouri, USA) and sulfatase (2 U/mL urine, Cat. No. S-9751, Sigma, St. Louis, Missouri, USA) for 16 hours at 37&#x000b0;C. The urine was then poured through a C-18 silica-gel column (Waters Corp, Milford, Massachusetts, USA), and the organics were eluted with 10 mL of methanol, which was then solvent-exchanged into dimethyl sulfoxide (DMSO) to produce an organic concentrate at 150X; concentrates were stored at 4&#x000b0;C until used for bioassay. Methanol/C-18 blanks were also prepared and tested for mutagenicity.</p><p id="P16">We used the <italic toggle="yes">Salmonella</italic> (Ames) mutagenicity assay with strain YG1041 in the plate-incorporation method to evaluate the organic concentrates of the urine samples as described previously.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> Briefly, the concentrates were evaluated at 0.3, 0.6, 1.2, 3, 6 and 12 ml-equivalents (ml-eq) of urine at one plate per dose. All experiments were performed with metabolic activation (S9 mix) made from Aroclor-induced, Sprague-Dawley rat-liver S9 (Moltox, Boone, North Carolina, USA). Plates were incubated at 37&#x000b0;C for 3 days, after which the colonies were counted on an automatic colony counter (ProtoCOL 3, Synbiosis, Frederick, Maryland, USA). We used DMSO at 100 &#x003bc;L/plate as the negative control. The positive controls were 2-nitrofluorene at 3 &#x003bc;g/plate in the absence of S9 and 2-aminoanthgracene at 0.5 &#x003bc;g/plate in the presence of S9. The coefficient of variation (CV) for urinary mutagenicity was not calculated because enough sample was available to test only once.</p><p id="P17">Oxidative stress biomarkers were measured in raw urine aliquots. Concentrations of 8-isoprostane and Ox-GS were measured using commercially available ELISA kits (Cayman, Ann Arbor, Michigan, USA). MDA level was determined using a colorimetric assay kit (Cayman, Ann Arbor, Michigan, USA). Standards and samples were measured in duplicate or triplicate according to the manufacturer&#x02019;s instructions. The CV for 8-isoprostane, MDA and Ox-GS are 14.90, 3.10, 9.92%, respectively. Urinary creatinine level was measured using a colorimetric kit (Cayman, Ann Arbor, Michigan, USA). Both non-creatinine-corrected (crude) and creatinine-corrected urinary biomarker concentrations were presented. The samples were banked and run as a group for the analyses.</p></sec><sec id="S10"><title>Statistical analyses</title><p id="P18">The slope of the linear regressions over the linear portion of the dose&#x02013;response curves, expressed as revertants/ml-eq, was used to determine the mutagenic potency. The linear portion of the curve was defined by the initial doses that gave the highest r<sup>2</sup> value that also had a p&#x02264;0.05 based on a trend test. Samples that did not achieve both requirements were given mutagenic potency of zero.</p><p id="P19">Cross-shift changes in biomarkers and whether these changes were different between burn and non-burn days were analysed using linear mixed-effect models (LMMs) with the subject and date included as random effect variables. Because urinary biomarkers were not distributed normally, the concentrations were log-transformed to achieve normality before being included in the models. To estimate cross-shift changes, an intercept-only model was used in which the log-differences were the dependent variables. The difference in cross-shift changes on burn day between tasks (holding or lighting) was also analysed using LMMs while controlling for potential confounders including career length, smoking status, chewing of tobacco, eating grilled foods, shift duration and acreage of burn. Only duration and acres, which were uncorrelated, were significant for some of the biomarkers and, thus, were included in the final model. LMMs were also used to analyse the associations between the concentrations of air pollutants in WFS and the cross-shift changes in the biomarkers. PM<sub>2.5</sub> and BC data were also log-transformed to achieve normality. The association between urinary biomarkers was analysed using Pearson correlation. All statistical analyses were performed using SAS (V.9.4), and p&#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec id="S11"><title>RESULTS</title><p id="P20">Analyses were done for a total of 120 spot urine samples from 19 firefighters (age&#x02212;35.0&#x000b1;7.2 years; career length&#x02212;9.2&#x000b1;6.8 years). Of these, 81 and 39 urine samples were collected on 7 burn days and 3 non-burn days, respectively. All samples collected on burn days were completely paired. There were 15 urine sample sets collected on non-burn days, and of these 1 and 5 sample sets did not have post-shift and next-morning samples, respectively. The average length of time spent at prescribed burn shifts was 4.98&#x000b1;1.34 hours, and the average area burned was 301.19&#x000b1;157.86 acres. At prescribed burns, geometric mean concentrations of personal exposure to PM<sub>2.5</sub> and BC were 1.36&#x000b1;0.16 mg/m<sup>3</sup> and 59.39&#x000b1;8.68 &#x003bc;g/m<sup>3</sup>, respectively.</p><p id="P21">The percentages of zero urinary mutagenicity were 33% in pre-shifts, 11% in post-shifts and 37% in next-morning of burn days, and the corresponding percentages on non-burn days were 47%, 31% and 45%. Crude and creatinine-corrected urinary biomarker concentrations on prescribed burn and regular workdays are presented in <xref rid="T1" ref-type="table">table 1</xref>, and cross-shift changes in the biomarkers examined using LMMs are shown in <xref rid="T2" ref-type="table">table 2</xref>. Crude values of urinary mutagenicity, 8-isoprostane and MDA increased significantly from pre-shift to post-shift on burn days (2.56&#x000d7;, 2.45&#x000d7; and 1.56&#x000d7;, p&#x0003c;0.01) and returned to a level similar to that of the pre-shift the next morning.</p><p id="P22">Except for pre-shift to next-morning changes in crude urinary 8-isoprostane and MDA (1.77&#x000d7; and 1.34&#x000d7;, p&#x0003c;0.05), no other significant temporal change in the levels of urinary biomarkers was observed for non-burn days. Post-exposure levels of creatinine-corrected mutagenicity and 8-isoprostane were non-significantly higher than pre-exposure levels on burn days (1.16&#x000d7; and 1.64&#x000d7;; p=0.09 and 0.07), whereas creatinine-corrected 8-isoprostane decreased non-significantly in post-shift on non-burn days (0.62&#x000d7;, p=0.08). Creatinine-corrected Ox-GS levels increased significantly in the next-morning compared with pre-shift on burn days (1.62&#x000d7;, p=0.03). No significant temporal change in creatinine-corrected urinary biomarkers was observed on non-burn days.</p><p id="P23">Differences in cross-shift changes in crude and creatinine-corrected values of urinary biomarkers between burn and non-burn days are shown in <xref rid="T3" ref-type="table">table 3</xref>. Pre-shift to post-shift changes in crude values of urinary mutagenicity, 8-isoprostane and MDA were 2.79-fold, 3.72-fold and 1.72-fold higher on burn days than on non-burn days (p=0.02, 0.01 and 0.03). Following creatinine correction, pre-shift to post-shift change in urinary 8-isoprostane and pre-morning to next morning change in Ox-GS on burn days were 2.64 (p=0.03) and 3.00 (p=0.02) times greater than the changes on non-burn days.</p><p id="P24">The effects of work tasks on cross-shift changes in urinary biomarker levels are presented in <xref rid="T4" ref-type="table">table 4</xref>. No significant effect on pre-shift to post-shift changes was observed. However, WLFFs who performed holding had 1.56 times higher pre-morning to next-morning changes in the levels of creatinine-corrected urinary mutagenicity compared with those who lighted during prescribed burns (p=0.03). Cross-shift change in urinary mutagenic potency was also associated significantly with the length of smoke exposure (p=0.01).</p><p id="P25">Results of the evaluation of the association between exposure to air pollutants in WFS during prescribed burns and cross-shift changes in urinary biomarker levels are presented in <xref rid="T5" ref-type="table">table 5</xref>. BC exposure concentration was correlated positively with pre-shift to post-shift change in urinary MDA level (&#x003b2;=0.36, p=0.01) but correlated negatively with pre-morning to next-morning change in urinary mutagenic potency (&#x003b2;=&#x02013;0.27, p=0.04). PM<sub>2.5</sub> and OC exposure concentrations were not associated with the urinary biomarkers (<xref rid="SD1" ref-type="supplementary-material">online supplemental table S1</xref>).</p><p id="P26">Pre-morning to next-morning changes in creatinine-corrected 8-isoprostane and MDA were significantly correlated (r=0.59, p&#x0003c;0.01).</p></sec><sec id="S12"><title>DISCUSSION</title><p id="P27">The assessment of related health responses of WFS exposure among WLFFs has been geographically limited to Southeastern and Western USA, where vegetative fuels might be different from the Midwest. In Ohio, the most dominant forest type is oak (~60%),<sup><xref rid="R24" ref-type="bibr">24</xref></sup> whereas pine (~40%) and fir groups (~40%) are the major forest types in the Southeast and West, respectively.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> Furthermore, prescribed burn is mostly conducted in the Southeast (64%) followed by the West (33%) and the Northeast (3%).<sup><xref rid="R26" ref-type="bibr">26</xref></sup> Therefore, distinct urinary mutagenicity and oxidative injuries might be observed among WLFFs in the Midwest due to WFS exposure from combustion of different forest fuels and loads.</p><sec id="S13"><title>Urinary mutagenicity</title><p id="P28">Investigation of urinary mutagenic activity offers a quantitative assessment of integrated exposure to mutagens in the biomass/wood smoke. Additionally, elevated urinary mutagenicity has been reported to be associated with increased cancer risk.<sup><xref rid="R5" ref-type="bibr">5</xref>
<xref rid="R7" ref-type="bibr">7</xref>
<xref rid="R8" ref-type="bibr">8</xref>
<xref rid="R27" ref-type="bibr">27</xref></sup></p><p id="P29">In this study, the levels of creatinine-corrected urinary mutagenicity in WLFFs before, after and the morning following prescribed burns were approximately 5.3-fold, 6.4-fold and 6.4-fold higher, respectively, compared with those from a similar study conducted in the Southeastern USA.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Creatinine-corrected mutagenic potencies in pre-shift, post-shift and next-morning on non-burn days were also 3.4-fold, 5.6-fold and 5.4-fold higher in the current study, respectively.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> The study design used in both studies are comparable. Both report urinary mutagenicity and 8-isoprostane levels in pre-shift, post-shift and next morning of burn and non-burn days. However, personal PM<sub>2.5</sub> exposure concentration in this study was ~5-fold higher than in the Southeastern study. These results suggest that WLFFS working in the Midwest had three to five times higher mutagenic exposures than those in the other study.<sup><xref rid="R5" ref-type="bibr">5</xref>
<xref rid="R16" ref-type="bibr">16</xref>
<xref rid="R28" ref-type="bibr">28</xref>&#x02013;<xref rid="R30" ref-type="bibr">30</xref></sup></p><p id="P30">Similarly, pre-exposure and post-exposure levels of creatinine-corrected mutagenic potencies on burn days in our study were 3.2-fold and 2.1-fold higher than the corresponding potencies reported in wood-fire steam bath users.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> WLFFs in our study who performed the holding task had higher levels of urinary mutagenicity than did those who performed lighting. The holding task was associated with exposure to smouldering emissions, which have much higher mutagenicity emission factors than do flaming emissions.<sup><xref rid="R14" ref-type="bibr">14</xref></sup></p><p id="P31">Nonetheless, the firefighters in our study had pre-exposure and post-exposure levels of urinary mutagenicity that were 1.2-fold to 2.3-fold less than those reported for charcoal workers in South America.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> Although WLFFs are also exposed dermally to biomass smoke, the charcoal workers probably experienced more dermal exposure because firefighters have a relatively higher dermal protection against occupational smoke exposure. The higher urinary mutagenicity of the charcoal workers could also be due to their routine exposure to biomass smoke, unlike the intermittent exposures of the WLFFs.</p><p id="P32">Both crude and creatinine-corrected urinary mutagenicity increased among firefighters following WFS exposure. WLFFs working in the southeast had a 1.6-fold higher creatinine-corrected cross-shift change in urinary mutagenicity on burn days compared with non-burn days.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Following combustion smoke exposure, urinary mutagenicity increased by 1.9-fold and 1.7-fold among Ottawa municipal firefighters and wood-fire steam bath users, respectively.<sup><xref rid="R6" ref-type="bibr">6</xref>
<xref rid="R7" ref-type="bibr">7</xref></sup> These results combined with our findings demonstrate that combustion emissions are capable of causing systemic mutagenicity among exposed individuals. However, the smaller cross-shift changes observed in this study might be due to a higher baseline level (pre-shift and non-burn days) of urinary mutagenicity in the WLFFs. Such high baseline might be due to repeated exposure of WLFFs in this study to more elevated WFS. Also, higher pre-existing elevated levels of urinary mutagenicity could attenuate the cross-shift changes on burn days and differences in the changes between burn and non-burn days in this study.</p><p id="P33">Unlike the findings in the Southeastern study,<sup><xref rid="R5" ref-type="bibr">5</xref></sup> WLFFs in this study who performed holding had a higher increase in creatinine-corrected urinary mutagenicity from pre-morning to next-morning compared with those who performed lighting (<xref rid="T4" ref-type="table">table 4</xref>). Meanwhile, exposure concentration of PM<sub>2.5</sub> was 1.5-fold higher in holding compared with lighting firefighters (data not shown). Although the Southeastern study indicated that exposure to both diesel and woodsmoke might induce an additive or synergistic effect on urinary mutagenicity,<sup><xref rid="R5" ref-type="bibr">5</xref></sup> the results in this study suggest that increased urinary mutagenicity was due primarily to exposure to particulate-phase and gas-phase mutagens in WFS.</p><p id="P34">Nonetheless, cross-shift change in creatinine-corrected urinary mutagenicity was not associated with personal PM<sub>2.5</sub> concentration. Instead, pre-morning to next-morning change in the mutagenicity was correlated negatively with BC exposure and BC to PM<sub>2.5</sub> ratio, which were higher among lighters (data not shown). These findings suggest that personal exposure concentration might not necessarily represent internal dose among the exposed firefighters.</p></sec><sec id="S14"><title>Urinary oxidative status</title><p id="P35">Oxidative stress is a series of imbalances between ROS production and the capacity of antioxidant defence in cells. Exposure to biomass-burning smoke is capable of inducing free radical-related oxidation in cells,<sup><xref rid="R1" ref-type="bibr">1</xref></sup> and urinary biomarkers are often used to study redox balance among exposed individuals.<sup><xref rid="R5" ref-type="bibr">5</xref>
<xref rid="R8" ref-type="bibr">8</xref>
<xref rid="R16" ref-type="bibr">16</xref>
<xref rid="R17" ref-type="bibr">17</xref></sup> Oxidative stress is an important pathogenic process that is associated with many diseases such as cardiovascular disease and cancer.<sup><xref rid="R31" ref-type="bibr">31</xref></sup></p><p id="P36">Pre-shift, post-shift and next-morning creatinine-corrected 8-isoprostane levels on burn and non-burn days were 2.6&#x02013;5.7 and 1.3&#x02013;4.1 times higher in the current study than those measured at corresponding work shift days in Southeastern USA.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Although creatinine-corrected 8-isoprostane was not reported in a study conducted among western WLFFs,<sup><xref rid="R17" ref-type="bibr">17</xref></sup> the average crude value of urinary 8-isoprostane on non-burn days observed in this study was 1.4-fold higher. Unlike WLFFs in the Southeastern US study, we observed a significant difference of pre-shift to post-shift change in creatinine-corrected 8-isoprostane between burn and non-burn days (<xref rid="T3" ref-type="table">table 3</xref>). Again, the higher WFS exposure concentration of prescribed burns in this study could be the possible explanation.</p><p id="P37">We also observed a non-significant 1.64-fold increase in creatinine-corrected 8-isoprostane in the morning following prescribed burns (<xref rid="T2" ref-type="table">table 2</xref>). Similar observations were made in a controlled human exposure study in which 8-iso-PGF&#x003b1; was 1.45-fold and 1.20-fold greater among healthy adults in the post-morning and next morning following woodsmoke exposure, respectively.<sup><xref rid="R21" ref-type="bibr">21</xref></sup> In addition, WLFFs in our study had a 1.6&#x02013;3.6 times higher level of creatinine-corrected 8-isoprostane compared with cigarette smokers in previous cross-sectional studies.<sup><xref rid="R32" ref-type="bibr">32</xref>&#x02013;<xref rid="R34" ref-type="bibr">34</xref></sup> It is worth noting that the concentration of urinary 8-isoprostane determined by ELISA is ~40% greater than the concentration obtained from analysis by liquid chromatography&#x02013;mass spectrometry.<sup><xref rid="R35" ref-type="bibr">35</xref></sup> Considering the different sensitivities of these analytical methods, WLFFs in this study still may have a higher level of urinary 8-isoprostane compared with the general population, including smokers.</p><p id="P38">Likewise, creatinine-corrected MDA levels observed before, after and the morning following burn and non-burn days in our study were 4.2&#x02013;6.3 and 4.8&#x02013;6.8 times higher than the corresponding levels reported in the Southeastern study (&#x003bc;mol/g creatinine=113 &#x003bc;mol MDA/mole creatinine).<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Pre-exposure and post-exposure levels of creatinine-corrected MDA in the present study were ~4-fold higher compared with those from another WLFF study in the Southeast.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> The urinary MDA concentrations presented here were determined using the trichloroacetic acid method in which MDA in the sample reacts with thiobarbituric acid (TBA) to form red MDA-TBA adducts that are colorimetrically quantified at 530 nm. Therefore, increased urinary MDA levels observed in this study could be due to higher WFS exposure concentration and/or different analytical methods for urinary MDA.</p><p id="P39">In comparison with a population-based study that used gas chromatography&#x02013;mass spectrometry to determine urinary MDA level, crude urinary MDA concentrations among healthy adults in a woodsmoke-impacted community were 1.5&#x02013;2.5 times lower than those measured among WLFFs in this study.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> Furthermore, an increased MDA level in exhaled breath condensate collected from healthy adults following a 4-hour woodsmoke exposure was observed in two controlled human exposure studies.<sup><xref rid="R36" ref-type="bibr">36</xref>
<xref rid="R37" ref-type="bibr">37</xref></sup> The results described above, along with our findings, suggest that woodsmoke exposure could lead to both local and systemic oxidative effects among exposed individuals. In this study, we observed that pre-shift to post-shift changes in MDA levels were correlated positively with BC concentration (<xref rid="T5" ref-type="table">table 5</xref>). Similarly, a positive effect of indoor BC exposure on urinary MDA among smokers with diagnosed chronic obstructive pulmonary disease was reported in a recent study.<sup><xref rid="R38" ref-type="bibr">38</xref></sup></p><p id="P40">Different analytical methods used to determine different damaged nucleic acid species make a direct comparison difficult between our study and the other studies. We measured the sum of damaged nucleic acid species (8-OHdG, 8-OHG and 8-OHGua) in the urine sample using ELISA, whereas the others often reported one of the species determined by high-performance liquid chromatography.<sup><xref rid="R16" ref-type="bibr">16</xref>
<xref rid="R22" ref-type="bibr">22</xref></sup> However, our results were consistent with previous studies, showing that DNA/RNA damage decreased non-significantly by ~20% after WFS exposure but increased nearly twofold the next morning (<xref rid="T1" ref-type="table">table 1</xref>). Similarly, in a Southeastern WLFF study, post-exposure levels of 8-Oxo-dG dropped ~14% compared with pre-exposure level.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> In an experimental woodsmoke exposure study, urinary excretion of 8-OxoGua in healthy adults increased non-significantly ~2-fold following 20 hours after leaving the exposure chamber.<sup><xref rid="R22" ref-type="bibr">22</xref></sup></p><p id="P41">PM-mediated oxidative stress and/or inflammation are postulated to induce oxidative DNA damage.<sup><xref rid="R39" ref-type="bibr">39</xref></sup> This hypothesis is supported by the significant difference of pre-morning to next-morning changes in oxidative DNA/RNA damage between burn and non-burn days in this study (<xref rid="T3" ref-type="table">table 3</xref>). These results suggest that oxidative DNA/RNA damage might be a delayed response to the effect of biomass smoke exposure compared with other oxidative effects.</p><p id="P42">In conclusion, urinary biomarkers used in this study reflected the effect of WFS exposure on acute health responses among exposed individuals. Our results suggest that WLFFs working in the Midwestern region of the USA may have an increased risk of systemic exposure to mutagens and oxidative injury due to repeated exposure to elevated levels of WFS compared with those working in the Southeastern and Western USA.</p></sec></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supplement1</label><media xlink:href="NIHMS1871289-supplement-Supplement1.pdf" id="d64e528" position="anchor"/></supplementary-material></sec></body><back><ack id="S15"><title>Acknowledgements</title><p id="P43">Our sincere thanks go to Ryan Sundberg, Jason Bew, and the Wayne National Forest crew and wildland firefighters who participated in this study. We also thank W. Kyle Martin (University of North Carolina at Chapel Hill) for training Chieh-Ming Wu on how to perform the urinary organic extractions.</p><sec id="S16"><title>Funding</title><p id="P44">This study was supported by: (1) the Grant or Cooperative Agreement Number, T42-OH008455, funded by the Centers for Disease Control and Prevention.</p><p id="P45">(2) Alumni Grants for Graduate Research and Scholarship (AGGRS) at The Ohio State University. The organic extractions and urinary mutagenicity experiments were performed at the US Environmental Protection Agency, Research Triangle Park, North Carolina, and supported by the intramural research program of the Office of Research and Development of the US EPA, Research Triangle Park, North Carolina.</p></sec></ack><fn-group><fn id="FN2"><p id="P47"><bold>Disclaimer</bold> The paper contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. This paper has been reviewed and approved for publication by the Center for Computational Toxicology and Exposure, Office of Research and Development, US Environmental Protection Agency. Approval does not signify that the contents necessarily reflect the views and policies of the US EPA, nor does mention of trade names or commercial products constitute endorsement or recommendation of use.</p></fn><fn fn-type="COI-statement" id="FN3"><p id="P48"><bold>Competing interests</bold> None declared.</p></fn><fn id="FN4"><p id="P49"><bold>Patient consent for publication</bold> Not required.</p></fn><fn id="FN5"><p id="P50"><bold>Ethics approval</bold> The protocol was reviewed and approved by The Ohio State University Institutional Review Board (2017H0075). Informed consent was obtained from each participant prior to their enrolment.</p></fn><fn id="FN6"><p id="P51"><bold>Provenance and peer review</bold> Not commissioned; externally peer reviewed.</p></fn><fn id="FN7"><p id="P52"><bold>Supplemental material</bold> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p></fn><fn id="FN8"><p id="P53">Supplemental material is published online only. To view please visit the journal online (<ext-link xlink:href="http://dx.doi.org/10.1136/oemed-2020-106612" ext-link-type="uri">http://dx.doi.org/10.1136/oemed-2020&#x02013;106612</ext-link>).</p></fn></fn-group><sec sec-type="data-availability" id="S17"><title>Data availability statement</title><p id="P46">Data are available upon reasonable request. De-identified data are available upon request to the corresponding author (<email>adetona.1@ osu.edu</email>).</p></sec><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><name><surname>Naeher</surname><given-names>LP</given-names></name>, <name><surname>Brauer</surname><given-names>M</given-names></name>, <name><surname>Lipsett</surname><given-names>M</given-names></name>, <etal/>
<article-title>Woodsmoke health effects: a review</article-title>. <source>Inhal Toxicol</source>
<year>2007</year>;<volume>19</volume>:<fpage>67</fpage>&#x02013;<lpage>106</lpage>.</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><name><surname>Adetona</surname><given-names>O</given-names></name>, <name><surname>Reinhardt</surname><given-names>TE</given-names></name>, <name><surname>Domitrovich</surname><given-names>J</given-names></name>, <etal/>
<article-title>Review of the health effects of wildland fire smoke on wildland firefighters and the public</article-title>. <source>Inhal Toxicol</source>
<year>2016</year>;<volume>28</volume>:<fpage>95</fpage>&#x02013;<lpage>139</lpage>.<pub-id pub-id-type="pmid">26915822</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><name><surname>Black</surname><given-names>C</given-names></name>, <name><surname>Tesfaigzi</surname><given-names>Y</given-names></name>, <name><surname>Bassein</surname><given-names>JA</given-names></name>, <etal/>
<article-title>Wildfire smoke exposure and human health: significant gaps in research for a growing public health issue</article-title>. <source>Environ Toxicol Pharmacol</source>
<year>2017</year>;<volume>55</volume>:<fpage>186</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">28892756</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><name><surname>Cascio</surname><given-names>WE</given-names></name>. <article-title>Wildland fire smoke and human health</article-title>. <source>Sci Total Environ</source>
<year>2018</year>;<volume>624</volume>:<fpage>586</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">29272827</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><name><surname>Adetona</surname><given-names>AM</given-names></name>, <name><surname>Martin</surname><given-names>WK</given-names></name>, <name><surname>Warren</surname><given-names>SH</given-names></name>, <etal/>
<article-title>Urinary mutagenicity and other biomarkers of occupational smoke exposure of wildland firefighters and oxidative stress</article-title>. <source>Inhal Toxicol</source>
<year>2019</year>;<volume>31</volume>:<fpage>73</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">30985217</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><name><surname>Keir</surname><given-names>JLA</given-names></name>, <name><surname>Akhtar</surname><given-names>US</given-names></name>, <name><surname>Matschke</surname><given-names>DMJ</given-names></name>, <etal/>
<article-title>Elevated exposures to polycyclic aromatic hydrocarbons and other organic mutagens in Ottawa firefighters participating in emergency, On-Shift fire suppression</article-title>. <source>Environ Sci Technol</source>
<year>2017</year>;<volume>51</volume>:<fpage>12745</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">29043785</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><name><surname>Long</surname><given-names>AS</given-names></name>, <name><surname>Lemieux</surname><given-names>CL</given-names></name>, <name><surname>Yousefi</surname><given-names>P</given-names></name>, <etal/>
<article-title>Human urinary mutagenicity after wood smoke exposure during traditional temazcal use</article-title>. <source>Mutagenesis</source>
<year>2014</year>;<volume>29</volume>:<fpage>367</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">25084778</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><name><surname>Kato</surname><given-names>M</given-names></name>, <name><surname>Loomis</surname><given-names>D</given-names></name>, <name><surname>Brooks</surname><given-names>LM</given-names></name>, <etal/>
<article-title>Urinary biomarkers in charcoal workers exposed to wood smoke in Bahia state, Brazil</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>
<year>2004</year>;<volume>13</volume>:<fpage>1005</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">15184257</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><name><surname>DeMarini</surname><given-names>DM</given-names></name>, <name><surname>Brooks</surname><given-names>LR</given-names></name>, <name><surname>Bhatnagar</surname><given-names>VK</given-names></name>, <etal/>
<article-title>Urinary mutagenicity as a biomarker in workers exposed to benzidine: correlation with urinary metabolites and urothelial DNA adducts</article-title>. <source>Carcinogenesis</source>
<year>1997</year>;<volume>18</volume>:<fpage>981</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">9163684</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><name><surname>Sabbioni</surname><given-names>G</given-names></name>, <name><surname>Jones</surname><given-names>CR</given-names></name>, <name><surname>Sepai</surname><given-names>O</given-names></name>, <etal/>
<article-title>Biomarkers of exposure, effect, and susceptibility in workers exposed to nitrotoluenes</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>
<year>2006</year>;<volume>15</volume>:<fpage>559</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">16537716</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><name><surname>Cern&#x000e1;</surname><given-names>M</given-names></name>, <name><surname>Pastorkov&#x000e1;</surname><given-names>A</given-names></name>, <name><surname>Myers</surname><given-names>SR</given-names></name>, <etal/>
<article-title>The use of a urine mutagenicity assay in the monitoring of environmental exposure to genotoxins</article-title>. <source>Mutat Res</source>
<year>1997</year>;<volume>391</volume>:<fpage>99</fpage>&#x02013;<lpage>110</lpage>.<pub-id pub-id-type="pmid">9219554</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><name><surname>Siwi&#x00144;ska</surname><given-names>E</given-names></name>, <name><surname>Mielzy&#x00144;ska</surname><given-names>D</given-names></name>, <name><surname>Kapka</surname><given-names>L</given-names></name>. <article-title>Association between urinary 1-hydroxypyrene and genotoxic effects in coke oven workers</article-title>. <source>Occup Environ Med</source>
<year>2004</year>;<volume>61</volume>:<fpage>10e</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><name><surname>Vermeulen</surname><given-names>R</given-names></name>, <name><surname>Bos</surname><given-names>RP</given-names></name>, <name><surname>Pertijs</surname><given-names>J</given-names></name>, <etal/>
<article-title>Exposure related mutagens in urine of rubber workers associated with inhalable particulate and dermal exposure</article-title>. <source>Occup Environ Med</source>
<year>2003</year>;<volume>60</volume>:<fpage>97</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">12554836</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>YH</given-names></name>, <name><surname>Warren</surname><given-names>SH</given-names></name>, <name><surname>Krantz</surname><given-names>QT</given-names></name>, <etal/>
<article-title>Mutagenicity and lung toxicity of smoldering vs. Flaming emissions from various biomass fuels: implications for health effects from Wildland fires</article-title>. <source>Environ Health Perspect</source>
<year>2018</year>;<volume>126</volume>:<fpage>017011</fpage>.<pub-id pub-id-type="pmid">29373863</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><name><surname>Mutlu</surname><given-names>E</given-names></name>, <name><surname>Warren</surname><given-names>SH</given-names></name>, <name><surname>Ebersviller</surname><given-names>SM</given-names></name>, <etal/>
<article-title>Mutagenicity and pollutant emission factors of Solid-Fuel Cookstoves: comparison with other combustion sources</article-title>. <source>Environ Health Perspect</source>
<year>2016</year>;<volume>124</volume>:<fpage>974</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">26895221</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><name><surname>Adetona</surname><given-names>O</given-names></name>, <name><surname>Zhang</surname><given-names>JJ</given-names></name>, <name><surname>Hall</surname><given-names>DB</given-names></name>, <etal/>
<article-title>Occupational exposure to woodsmoke and oxidative stress in wildland firefighters</article-title>. <source>Sci Total Environ</source>
<year>2013</year>;<volume>449</volume>:<fpage>269</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">23434577</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><name><surname>Gaughan</surname><given-names>DM</given-names></name>, <name><surname>Siegel</surname><given-names>PD</given-names></name>, <name><surname>Hughes</surname><given-names>MD</given-names></name>, <etal/>
<article-title>Arterial stiffness, oxidative stress, and smoke exposure in wildland firefighters</article-title>. <source>Am J Ind Med</source>
<year>2014</year>;<volume>57</volume>:<fpage>748</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">24909863</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><name><surname>Commodore</surname><given-names>AA</given-names></name>, <name><surname>Zhang</surname><given-names>JJ</given-names></name>, <name><surname>Chang</surname><given-names>Y</given-names></name>, <etal/>
<article-title>Concentrations of urinary 8-hydroxy-2&#x02019;-deoxyguanosine and 8-isoprostane in women exposed to woodsmoke in a cookstove intervention study in San Marcos, Peru</article-title>. <source>Environ Int</source>
<year>2013</year>;<volume>60</volume>:<fpage>112</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">24041735</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><name><surname>Weinstein</surname><given-names>JR</given-names></name>, <name><surname>Asteria-Pe&#x000f1;aloza</surname><given-names>R</given-names></name>, <name><surname>Diaz-Artiga</surname><given-names>A</given-names></name>, <etal/>
<article-title>Exposure to polycyclic aromatic hydrocarbons and volatile organic compounds among recently pregnant rural Guatemalan women cooking and heating with solid fuels</article-title>. <source>Int J Hyg Environ Health</source>
<year>2017</year>;<volume>220</volume>:<fpage>726</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">28320639</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><name><surname>Allen</surname><given-names>RW</given-names></name>, <name><surname>Carlsten</surname><given-names>C</given-names></name>, <name><surname>Karlen</surname><given-names>B</given-names></name>, <etal/>
<article-title>An air filter intervention study of endothelial function among healthy adults in a woodsmoke-impacted community</article-title>. <source>Am J Respir Crit Care Med</source>
<year>2011</year>;<volume>183</volume>:<fpage>1222</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">21257787</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><name><surname>Barregard</surname><given-names>L</given-names></name>, <name><surname>S&#x000e4;llsten</surname><given-names>G</given-names></name>, <name><surname>Gustafson</surname><given-names>P</given-names></name>, <etal/>
<article-title>Experimental exposure to wood-smoke particles in healthy humans: effects on markers of inflammation, coagulation, and lipid peroxidation</article-title>. <source>Inhal Toxicol</source>
<year>2006</year>;<volume>18</volume>:<fpage>845</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">16864402</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><name><surname>Danielsen</surname><given-names>PH</given-names></name>, <name><surname>Br&#x000e4;uner</surname><given-names>EV</given-names></name>, <name><surname>Barregard</surname><given-names>L</given-names></name>, <etal/>
<article-title>Oxidatively damaged DNA and its repair after experimental exposure to wood smoke in healthy humans</article-title>. <source>Mutat Res</source>
<year>2008</year>;<volume>642</volume>:<fpage>37</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">18495177</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><name><surname>Garland</surname><given-names>C</given-names></name>, <name><surname>Delapena</surname><given-names>S</given-names></name>, <name><surname>Prasad</surname><given-names>R</given-names></name>, <etal/>
<article-title>Black carbon cookstove emissions: a field assessment of 19 stove/fuel combinations</article-title>. <source>Atmos Environ</source>
<year>2017</year>;<volume>169</volume>:<fpage>140</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="book"><name><surname>Albright</surname><given-names>TA</given-names></name>. <source>Forests of Ohio, 2017. resource update FS-171</source>. <publisher-loc>Newtown square, PA</publisher-loc>: <publisher-name>U.S. department of agriculture, forest service, Northern research station</publisher-name>, <year>2018</year>. Available: <pub-id pub-id-type="doi">10.2737/FS-RU-171</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="book"><collab>USDA.</collab>
<source>United States department of agriculture, forest service</source>. <publisher-name>National forest type dataset</publisher-name>, <year>2008</year>. Available: <comment><ext-link xlink:href="https://data.fs.usda.gov/geodata/rastergateway/forest_type/forestgroup_accuracy_tables.pdf" ext-link-type="uri">https://data.fs.usda.gov/geodata/rastergateway/forest_type/forestgroup_accuracy_tables.pdf</ext-link></comment> [<date-in-citation>Accessed 25 Mar 2020</date-in-citation>].</mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="book"><name><surname>Melvin</surname><given-names>MA</given-names></name>. <source>National prescribed fire use survey report</source>. <publisher-name>coalition of prescribed fire councils</publisher-name>, <year>2018</year>. Available: <comment><ext-link xlink:href="http://www.prescribedfire.net/resources-links" ext-link-type="uri">http://www.prescribedfire.net/resources-links</ext-link></comment></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><name><surname>Peters</surname><given-names>U</given-names></name>, <name><surname>DeMarini</surname><given-names>DM</given-names></name>, <name><surname>Sinha</surname><given-names>R</given-names></name>, <etal/>
<article-title>Urinary mutagenicity and colorectal adenoma risk</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>
<year>2003</year>;<volume>12</volume>:<fpage>1253</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">14652290</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><name><surname>Reinhardt</surname><given-names>TE</given-names></name>, <name><surname>Ottmar</surname><given-names>RD</given-names></name>. <article-title>Baseline measurements of smoke exposure among wildland firefighters</article-title>. <source>J Occup Environ Hyg</source>
<year>2004</year>;<volume>1</volume>:<fpage>593</fpage>&#x02013;<lpage>606</lpage>.<pub-id pub-id-type="pmid">15559331</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><name><surname>Adetona</surname><given-names>AM</given-names></name>, <name><surname>Adetona</surname><given-names>O</given-names></name>, <name><surname>Gogal</surname><given-names>RM</given-names></name>, <etal/>
<article-title>Impact of work Task-Related acute occupational smoke exposures on select proinflammatory immune parameters in Wildland firefighters</article-title>. <source>J Occup Environ Med</source>
<year>2017</year>;<volume>59</volume>:<fpage>679</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">28692002</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><name><surname>Adetona</surname><given-names>O</given-names></name>, <name><surname>Dunn</surname><given-names>K</given-names></name>, <name><surname>Hall</surname><given-names>DB</given-names></name>, <etal/>
<article-title>Personal PM(2.5) exposure among wildland firefighters working at prescribed forest burns in Southeastern United States</article-title>. <source>J Occup Environ Hyg</source>
<year>2011</year>;<volume>8</volume>:<fpage>503</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">21762011</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><name><surname>Il&#x02019;yasova</surname><given-names>D</given-names></name>, <name><surname>Scarbrough</surname><given-names>P</given-names></name>, <name><surname>Spasojevic</surname><given-names>I</given-names></name>. <article-title>Urinary biomarkers of oxidative status</article-title>. <source>Clinica Chimica Acta</source>
<year>2012</year>;<volume>413</volume>:<fpage>1446</fpage>&#x02013;<lpage>53</lpage>.</mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><name><surname>Liang</surname><given-names>Y</given-names></name>, <name><surname>Wei</surname><given-names>P</given-names></name>, <name><surname>Duke</surname><given-names>RW</given-names></name>, <etal/>
<article-title>Quantification of 8-iso-prostaglandin-F2&#x003b1; and 2,3-dinor-8-iso-prostaglandin-F2&#x003b1; in human urine using liquid chromatography-tandem mass spectrometry</article-title>. <source>Free Radical Biology and Medicine</source>
<year>2003</year>;<volume>34</volume>:<fpage>409</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">12566066</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>AW</given-names></name>, <name><surname>Bruno</surname><given-names>RS</given-names></name>, <name><surname>Traber</surname><given-names>MG</given-names></name>. <article-title>Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology</article-title>. <source>Lipids</source>
<year>2008</year>;<volume>43</volume>:<fpage>925</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">18751751</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><name><surname>Harman</surname><given-names>SM</given-names></name>, <name><surname>Liang</surname><given-names>L</given-names></name>, <name><surname>Tsitouras</surname><given-names>PD</given-names></name>, <etal/>
<article-title>Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers</article-title>. <source>Free Radic Biol Med</source>
<year>2003</year>;<volume>35</volume>:<fpage>1301</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">14607529</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><name><surname>Klawitter</surname><given-names>J</given-names></name>, <name><surname>Haschke</surname><given-names>M</given-names></name>, <name><surname>Shokati</surname><given-names>T</given-names></name>, <etal/>
<article-title>Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be compared</article-title>. <source>Rapid Commun Mass Spectrom</source>
<year>2011</year>;<volume>25</volume>:<fpage>463</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">21259353</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><name><surname>Barregard</surname><given-names>L</given-names></name>, <name><surname>S&#x000e4;llsten</surname><given-names>G</given-names></name>, <name><surname>Andersson</surname><given-names>L</given-names></name>, <etal/>
<article-title>Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress</article-title>. <source>Occup Environ Med</source>
<year>2008</year>;<volume>65</volume>:<fpage>319</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">17704195</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><name><surname>Stockfelt</surname><given-names>L</given-names></name>, <name><surname>Sallsten</surname><given-names>G</given-names></name>, <name><surname>Olin</surname><given-names>A-C</given-names></name>, <etal/>
<article-title>Effects on airways of short-term exposure to two kinds of wood smoke in a chamber study of healthy humans</article-title>. <source>Inhal Toxicol</source>
<year>2012</year>;<volume>24</volume>:<fpage>47</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">22220980</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><name><surname>Grady</surname><given-names>ST</given-names></name>, <name><surname>Koutrakis</surname><given-names>P</given-names></name>, <name><surname>Hart</surname><given-names>JE</given-names></name>, <etal/>
<article-title>Indoor black carbon of outdoor origin and oxidative stress biomarkers in patients with chronic obstructive pulmonary disease</article-title>. <source>Environ Int</source>
<year>2018</year>;<volume>115</volume>:<fpage>188</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">29574339</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><name><surname>M&#x000f8;ller</surname><given-names>P</given-names></name>, <name><surname>Danielsen</surname><given-names>PH</given-names></name>, <name><surname>Karottki</surname><given-names>DG</given-names></name>, <etal/>
<article-title>Oxidative stress and inflammation generated DNA damage by exposure to air pollution particles</article-title>. <source>Mutat Res Rev Mutat Res</source>
<year>2014</year>;<volume>762</volume>:<fpage>133</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">25475422</pub-id></mixed-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1</label><caption><p id="P54">Geometric mean (GM), geometric SD (GSD), and range for crude and creatinine-corrected values of urinary biomarkers in WLFFs by types of workday (prescribed burn or regular work) and time of sample collection (pre-shift, post-shift or next-morning)</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="3" align="left" valign="top" colspan="1"/><th colspan="2" align="left" valign="middle" rowspan="1">Prescribed burn (N=81)</th><th colspan="2" align="left" valign="middle" rowspan="1">Regular work (N=39)</th></tr><tr><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">GM&#x000b1;GSD</th><th align="left" valign="middle" rowspan="1" colspan="1">Range</th><th align="left" valign="middle" rowspan="1" colspan="1">GM&#x000b1;GSD</th><th align="left" valign="middle" rowspan="1" colspan="1">Range</th></tr><tr><th colspan="5" align="center" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td colspan="5" align="left" valign="top" rowspan="1">
<bold>Crude values</bold>
</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Urinary mutagenicity (rev/ml-eq)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pre-shift</td><td align="left" valign="top" rowspan="1" colspan="1">4.31&#x000b1;0.97</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;27.54</td><td align="left" valign="top" rowspan="1" colspan="1">3.92&#x000b1;1.36</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;18.95</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Post-shift</td><td align="left" valign="top" rowspan="1" colspan="1">11.03&#x000b1;2.54</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;72.86</td><td align="left" valign="top" rowspan="1" colspan="1">4.44&#x000b1;1.37</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;15.52</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Next-morning</td><td align="left" valign="top" rowspan="1" colspan="1">4.54&#x000b1;1.16</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;40.00</td><td align="left" valign="top" rowspan="1" colspan="1">3.65&#x000b1;1.44</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;23.81</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">8-isoprostane (ng/mL)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pre-shift</td><td align="left" valign="top" rowspan="1" colspan="1">1.30&#x000b1;0.31</td><td align="left" valign="top" rowspan="1" colspan="1">0.09&#x02013;15.15</td><td align="left" valign="top" rowspan="1" colspan="1">0.75&#x000b1;0.15</td><td align="left" valign="top" rowspan="1" colspan="1">0.17&#x02013;2.40</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Post-shift</td><td align="left" valign="top" rowspan="1" colspan="1">3.18&#x000b1;0.80</td><td align="left" valign="top" rowspan="1" colspan="1">0.15&#x02013;17.33</td><td align="left" valign="top" rowspan="1" colspan="1">0.51&#x000b1;0.18</td><td align="left" valign="top" rowspan="1" colspan="1">0.07&#x02013;3.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Next-morning</td><td align="left" valign="top" rowspan="1" colspan="1">1.62&#x000b1;0.39</td><td align="left" valign="top" rowspan="1" colspan="1">0.12&#x02013;9.07</td><td align="left" valign="top" rowspan="1" colspan="1">1.66&#x000b1;0.39</td><td align="left" valign="top" rowspan="1" colspan="1">0.36&#x02013;5.48</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">MDA (&#x003bc;M)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pre-shift</td><td align="left" valign="top" rowspan="1" colspan="1">4.07&#x000b1;0.53</td><td align="left" valign="top" rowspan="1" colspan="1">1.16&#x02013;12.05</td><td align="left" valign="top" rowspan="1" colspan="1">4.53&#x000b1;0.66</td><td align="left" valign="top" rowspan="1" colspan="1">1.47&#x02013;9.19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Post-shift</td><td align="left" valign="top" rowspan="1" colspan="1">6.36&#x000b1;1.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.58&#x02013;19.32</td><td align="left" valign="top" rowspan="1" colspan="1">4.26&#x000b1;0.64</td><td align="left" valign="top" rowspan="1" colspan="1">2.04&#x02013;10.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Next-morning</td><td align="left" valign="top" rowspan="1" colspan="1">3.91&#x000b1;0.51</td><td align="left" valign="top" rowspan="1" colspan="1">0.76&#x02013;9.64</td><td align="left" valign="top" rowspan="1" colspan="1">6.62&#x000b1;0.87</td><td align="left" valign="top" rowspan="1" colspan="1">3.01&#x02013;11.58</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Ox-GS (ng/mL)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pre-shift</td><td align="left" valign="top" rowspan="1" colspan="1">98.27&#x000b1;14.03</td><td align="left" valign="top" rowspan="1" colspan="1">18.91&#x02013;607.57</td><td align="left" valign="top" rowspan="1" colspan="1">114.55&#x000b1;26.60</td><td align="left" valign="top" rowspan="1" colspan="1">21.66&#x02013;1147.40</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Post-shift</td><td align="left" valign="top" rowspan="1" colspan="1">116.99&#x000b1;16.48</td><td align="left" valign="top" rowspan="1" colspan="1">24.93&#x02013;509.38</td><td align="left" valign="top" rowspan="1" colspan="1">129.66&#x000b1;39.24</td><td align="left" valign="top" rowspan="1" colspan="1">30.96&#x02013;1069.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Next-morning</td><td align="left" valign="top" rowspan="1" colspan="1">126.53&#x000b1;13.09</td><td align="left" valign="top" rowspan="1" colspan="1">49.71&#x02013;373.05</td><td align="left" valign="top" rowspan="1" colspan="1">76.67&#x000b1;14.56</td><td align="left" valign="top" rowspan="1" colspan="1">24.15&#x02013;220.10</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">
<bold>Creatinine-adjusted values</bold>
</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Urinary mutagenicity (rev/&#x003bc;mol creatinine)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pre-shift</td><td align="left" valign="top" rowspan="1" colspan="1">1.55&#x000b1;0.14</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;3.85</td><td align="left" valign="top" rowspan="1" colspan="1">1.53&#x000b1;0.19</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;3.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Post-shift</td><td align="left" valign="top" rowspan="1" colspan="1">1.80&#x000b1;0.13</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;2.83</td><td align="left" valign="top" rowspan="1" colspan="1">1.52&#x000b1;0.13</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;1.36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Next-morning</td><td align="left" valign="top" rowspan="1" colspan="1">1.67&#x000b1;0.19</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;6.96</td><td align="left" valign="top" rowspan="1" colspan="1">1.34&#x000b1;0.13</td><td align="left" valign="top" rowspan="1" colspan="1">0.00&#x02013;1.38</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">8-isoprostane (ng/mg creatinine)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pre-shift</td><td align="left" valign="top" rowspan="1" colspan="1">1.05&#x000b1;0.21</td><td align="left" valign="top" rowspan="1" colspan="1">0.13&#x02013;15.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.82&#x000b1;0.13</td><td align="left" valign="top" rowspan="1" colspan="1">0.17&#x02013;2.18</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Post-shift</td><td align="left" valign="top" rowspan="1" colspan="1">1.72&#x000b1;0.36</td><td align="left" valign="top" rowspan="1" colspan="1">0.37&#x02013;125.09</td><td align="left" valign="top" rowspan="1" colspan="1">0.50&#x000b1;0.12</td><td align="left" valign="top" rowspan="1" colspan="1">0.13&#x02013;1.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Next-morning</td><td align="left" valign="top" rowspan="1" colspan="1">1.72&#x000b1;0.47</td><td align="left" valign="top" rowspan="1" colspan="1">0.08&#x02013;66.90</td><td align="left" valign="top" rowspan="1" colspan="1">0.96&#x000b1;0.20</td><td align="left" valign="top" rowspan="1" colspan="1">0.20&#x02013;2.53</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">MDA (&#x003bc;mol/g creatinine)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pre-shift</td><td align="left" valign="top" rowspan="1" colspan="1">3.28&#x000b1;0.29</td><td align="left" valign="top" rowspan="1" colspan="1">1.26&#x02013;7.63</td><td align="left" valign="top" rowspan="1" colspan="1">4.94&#x000b1;0.61</td><td align="left" valign="top" rowspan="1" colspan="1">2.74&#x02013;14.44</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Post-shift</td><td align="left" valign="top" rowspan="1" colspan="1">3.43&#x000b1;0.23</td><td align="left" valign="top" rowspan="1" colspan="1">1.69&#x02013;7.29</td><td align="left" valign="top" rowspan="1" colspan="1">4.15&#x000b1;0.45</td><td align="left" valign="top" rowspan="1" colspan="1">2.42&#x02013;8.74</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Next-morning</td><td align="left" valign="top" rowspan="1" colspan="1">4.17&#x000b1;0.45</td><td align="left" valign="top" rowspan="1" colspan="1">1.49&#x02013;17.17</td><td align="left" valign="top" rowspan="1" colspan="1">3.81&#x000b1;0.59</td><td align="left" valign="top" rowspan="1" colspan="1">2.08&#x02013;10.78</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Ox-GS (ng/mg creatinine)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pre-shift</td><td align="left" valign="top" rowspan="1" colspan="1">83.04&#x000b1;16.06</td><td align="left" valign="top" rowspan="1" colspan="1">12.63&#x02013;901.98</td><td align="left" valign="top" rowspan="1" colspan="1">101.99&#x000b1;32.67</td><td align="left" valign="top" rowspan="1" colspan="1">8.67&#x02013;501.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Post-shift</td><td align="left" valign="top" rowspan="1" colspan="1">67.54&#x000b1;15.55</td><td align="left" valign="top" rowspan="1" colspan="1">10.23&#x02013;1142.56</td><td align="left" valign="top" rowspan="1" colspan="1">91.46&#x000b1;38.25</td><td align="left" valign="top" rowspan="1" colspan="1">8.35&#x02013;1180.23</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Next-morning</td><td align="left" valign="top" rowspan="1" colspan="1">134.77&#x000b1;31.34</td><td align="left" valign="top" rowspan="1" colspan="1">15.80&#x02013;2644.84</td><td align="left" valign="top" rowspan="1" colspan="1">55.21&#x000b1;17.11</td><td align="left" valign="top" rowspan="1" colspan="1">10.18&#x02013;239.31</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P55">MDA, malondialdehyde; Ox-GS, oxidised guanine species; WLFFs, wildland firefighters.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="landscape"><label>Table 2</label><caption><p id="P56">Cross-shift changes (post-shift or next-morning vs pre-shift) in crude and creatinine-corrected values of urinary biomarkers in WLFFs on prescribed burn days or regular work days using linear mixed-effect models</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="3" align="left" valign="top" colspan="1"/><th colspan="2" align="left" valign="middle" rowspan="1">Prescribed burn</th><th colspan="2" align="left" valign="middle" rowspan="1">Regular work</th></tr><tr><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Ratio (95% CI)</th><th align="left" valign="middle" rowspan="1" colspan="1">P value</th><th align="left" valign="middle" rowspan="1" colspan="1">Ratio (95% CI)</th><th align="left" valign="middle" rowspan="1" colspan="1">P value</th></tr><tr><th colspan="5" align="center" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td colspan="5" align="left" valign="top" rowspan="1">
<bold>Crude values</bold>
</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Pre-shift to post-shift<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">2.56 (1.49&#x02013;4.40)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.92 (0.49&#x02013;1.73)</td><td align="left" valign="top" rowspan="1" colspan="1">0.77</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">2.45 (1.35&#x02013;4.41)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.66 (0.32&#x02013;1.36)</td><td align="left" valign="top" rowspan="1" colspan="1">0.23</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;MDA</td><td align="left" valign="top" rowspan="1" colspan="1">1.56 (1.16&#x02013;2.11)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.91 (0.60&#x02013;1.37)</td><td align="left" valign="top" rowspan="1" colspan="1">0.62</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Ox-GS</td><td align="left" valign="top" rowspan="1" colspan="1">1.19 (0.74&#x02013;1.91)</td><td align="left" valign="top" rowspan="1" colspan="1">0.46</td><td align="left" valign="top" rowspan="1" colspan="1">1.17 (0.49&#x02013;2.80)</td><td align="left" valign="top" rowspan="1" colspan="1">0.71</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Pre-morning to next-morning<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">1.05 (0.60&#x02013;1.85)</td><td align="left" valign="top" rowspan="1" colspan="1">0.85</td><td align="left" valign="top" rowspan="1" colspan="1">0.84 (0.26&#x02013;2.73)</td><td align="left" valign="top" rowspan="1" colspan="1">0.75</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">1.24 (0.69&#x02013;2.25)</td><td align="left" valign="top" rowspan="1" colspan="1">0.46</td><td align="left" valign="top" rowspan="1" colspan="1">1.77 (1.07&#x02013;2.95)</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;MDA</td><td align="left" valign="top" rowspan="1" colspan="1">0.96 (0.73&#x02013;1.27)</td><td align="left" valign="top" rowspan="1" colspan="1">0.77</td><td align="left" valign="top" rowspan="1" colspan="1">1.34 (1.01&#x02013;1.78)</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Ox-GS</td><td align="left" valign="top" rowspan="1" colspan="1">1.29 (0.86&#x02013;1.93)</td><td align="left" valign="top" rowspan="1" colspan="1">0.21</td><td align="left" valign="top" rowspan="1" colspan="1">0.69 (0.36&#x02013;1.33)</td><td align="left" valign="top" rowspan="1" colspan="1">0.23</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">
<bold>Creatinine-corrected values</bold>
</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Pre-shift to post-shift<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">1.16 (0.98&#x02013;1.39)</td><td align="left" valign="top" rowspan="1" colspan="1">0.09</td><td align="left" valign="top" rowspan="1" colspan="1">0.93 (0.74&#x02013;1.18)</td><td align="left" valign="top" rowspan="1" colspan="1">0.52</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">1.64 (0.95&#x02013;2.81)</td><td align="left" valign="top" rowspan="1" colspan="1">0.07</td><td align="left" valign="top" rowspan="1" colspan="1">0.62 (0.36&#x02013;1.08)</td><td align="left" valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;MDA</td><td align="left" valign="top" rowspan="1" colspan="1">1.04 (0.84&#x02013;1.30)</td><td align="left" valign="top" rowspan="1" colspan="1">0.69</td><td align="left" valign="top" rowspan="1" colspan="1">0.86 (0.65&#x02013;1.14)</td><td align="left" valign="top" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Ox-GS</td><td align="left" valign="top" rowspan="1" colspan="1">0.81 (0.47&#x02013;1.40)</td><td align="left" valign="top" rowspan="1" colspan="1">0.44</td><td align="left" valign="top" rowspan="1" colspan="1">0.87 (0.37&#x02013;2.03)</td><td align="left" valign="top" rowspan="1" colspan="1">0.72</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Pre-morning to next-morning<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">1.08 (0.88&#x02013;1.33)</td><td align="left" valign="top" rowspan="1" colspan="1">0.45</td><td align="left" valign="top" rowspan="1" colspan="1">0.87 (0.65&#x02013;1.16)</td><td align="left" valign="top" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">1.64 (0.77&#x02013;3.49)</td><td align="left" valign="top" rowspan="1" colspan="1">0.19</td><td align="left" valign="top" rowspan="1" colspan="1">1.12 (0.76&#x02013;1.65)</td><td align="left" valign="top" rowspan="1" colspan="1">0.54</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;MDA</td><td align="left" valign="top" rowspan="1" colspan="1">1.27 (0.94&#x02013;1.72)</td><td align="left" valign="top" rowspan="1" colspan="1">0.12</td><td align="left" valign="top" rowspan="1" colspan="1">0.84 (0.66&#x02013;1.08)</td><td align="left" valign="top" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Ox-GS</td><td align="left" valign="top" rowspan="1" colspan="1">1.62 (1.04&#x02013;2.53)</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.54 (0.18&#x02013;1.60)</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>*</label><p id="P57">Cross-shift changes were defined as log (post-shift or next-morning) versus log (pre-shift) and results were backlog-transformed. MDA, malondialdehyde; Ox-GS, oxidised guanine species; WLFFs, wildland firefighters.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3" orientation="landscape"><label>Table 3</label><caption><p id="P58">Comparison of cross-shift changes (post-shift or next-morning vs pre-shift) in crude and creatinine-corrected values of urinary biomarkers in WLFFs on prescribed burn days to regular workdays using linear mixed-effect models</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="3" align="left" valign="top" colspan="1"/><th colspan="2" align="left" valign="middle" rowspan="1">Pre-shift to post-shift<xref rid="TFN3" ref-type="table-fn">*</xref></th><th colspan="2" align="left" valign="middle" rowspan="1">Pre-shift to next-morning<xref rid="TFN3" ref-type="table-fn">*</xref></th></tr><tr><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Ratio (95% CI)</th><th align="left" valign="middle" rowspan="1" colspan="1">P value</th><th align="left" valign="middle" rowspan="1" colspan="1">Ratio (95% CI)</th><th align="left" valign="middle" rowspan="1" colspan="1">P value</th></tr><tr><th colspan="5" align="center" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td colspan="5" align="left" valign="top" rowspan="1">
<bold>Crude values</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">2.79 (1.16&#x02013;6.69)</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">1.25 (0.41&#x02013;3.76)</td><td align="left" valign="top" rowspan="1" colspan="1">0.69</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">3.72 (1.42&#x02013;9.75)</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.70 (0.27&#x02013;1.85)</td><td align="left" valign="top" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MDA</td><td align="left" valign="top" rowspan="1" colspan="1">1.72 (1.04&#x02013;2.84)</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.72 (0.45&#x02013;1.14)</td><td align="left" valign="top" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ox-GS</td><td align="left" valign="top" rowspan="1" colspan="1">1.02 (0.43&#x02013;2.45)</td><td align="left" valign="top" rowspan="1" colspan="1">0.96</td><td align="left" valign="top" rowspan="1" colspan="1">1.87 (0.90&#x02013;3.88)</td><td align="left" valign="top" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Creatinine-adjusted values</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">1.25 (0.93&#x02013;1.67)</td><td align="left" valign="top" rowspan="1" colspan="1">0.13</td><td align="left" valign="top" rowspan="1" colspan="1">1.24 (0.86&#x02013;1.79)</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">2.64 (1.13&#x02013;6.16)</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">1.47 (0.44&#x02013;4.85)</td><td align="left" valign="top" rowspan="1" colspan="1">0.52</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MDA</td><td align="left" valign="top" rowspan="1" colspan="1">1.21 (0.84&#x02013;1.75)</td><td align="left" valign="top" rowspan="1" colspan="1">0.29</td><td align="left" valign="top" rowspan="1" colspan="1">1.51 (0.92&#x02013;2.47)</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ox-GS</td><td align="left" valign="top" rowspan="1" colspan="1">0.94 (0.37&#x02013;2.41)</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">3.00 (1.19&#x02013;7.57)</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>*</label><p id="P59">Cross-shift changes were defined as log (post-shift or next-morning) versus log (pre-shift) and results were backlog-transformed. MDA, malondialdehyde; Ox-GS, oxidised guanine species; WLFFs, wildland firefighters.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p id="P60">Difference of cross-shift changes in creatinine-corrected values of urinary biomarkers in WLFFs due to different work tasks (ie, holding or lighting) during prescribed burns</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="3" align="left" valign="top" colspan="1"/><th colspan="2" align="left" valign="middle" rowspan="1">Work task<xref rid="TFN5" ref-type="table-fn">&#x02020;</xref></th></tr><tr><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Ratio (95% CI)</th><th align="left" valign="middle" rowspan="1" colspan="1">P value</th></tr><tr><th colspan="3" align="center" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td colspan="3" align="left" valign="top" rowspan="1">
<bold>Pre-shift to post-shift</bold>
<xref rid="TFN4" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">1.09 (0.73&#x02013;1.64)</td><td align="left" valign="top" rowspan="1" colspan="1">0.65</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">0.61 (0.18&#x02013;2.06)</td><td align="left" valign="top" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MDA</td><td align="left" valign="top" rowspan="1" colspan="1">0.70 (0.43&#x02013;1.13)</td><td align="left" valign="top" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ox-GS</td><td align="left" valign="top" rowspan="1" colspan="1">1.00 (0.29&#x02013;3.46)</td><td align="left" valign="top" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Pre-morning to next-morning</bold>
<xref rid="TFN4" ref-type="table-fn">*</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">1.56 (1.05&#x02013;2.31)</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">2.56 (0.53&#x02013;12.39)</td><td align="left" valign="top" rowspan="1" colspan="1">0.23</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MDA</td><td align="left" valign="top" rowspan="1" colspan="1">1.15 (0.61&#x02013;2.16)</td><td align="left" valign="top" rowspan="1" colspan="1">0.66</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ox-GS</td><td align="left" valign="top" rowspan="1" colspan="1">1.13 (0.40&#x02013;3.18)</td><td align="left" valign="top" rowspan="1" colspan="1">0.81</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>*</label><p id="P61">Cross-shift changes were defined as log (post-shift or next-morning) versus log (pre-shift) and results were backlog-transformed.</p></fn><fn id="TFN5"><label>&#x02020;</label><p id="P62">WLFFs worked holding task versus lighting task during prescribed burns. MDA, malondialdehyde; Ox-GS, oxidised guanine species; WLFFs, wildland firefighters.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T5" orientation="landscape"><label>Table 5</label><caption><p id="P63">Association between air pollutant concentrations in wildland fire smoke emission during prescribed burns and cross-shift changes (ie, post-shift or next-morning vs pre-shift) in creatinine-corrected values of urinary biomarkers in WLFFs</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="3" align="left" valign="top" colspan="1"/><th colspan="2" align="left" valign="middle" rowspan="1">PM<sub>2.5</sub> (mg/m<sup>3</sup>)</th><th colspan="2" align="left" valign="middle" rowspan="1">Black carbon (&#x003bc;g/m<sup>3</sup>)</th></tr><tr><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">&#x003b2; (95% CI)</th><th align="left" valign="middle" rowspan="1" colspan="1">P value</th><th align="left" valign="middle" rowspan="1" colspan="1">&#x003b2; (95% CI)</th><th align="left" valign="middle" rowspan="1" colspan="1">P value</th></tr><tr><th colspan="5" align="center" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td colspan="5" align="left" valign="top" rowspan="1">
<bold>Pre-shift to post-shift</bold>
<xref rid="TFN6" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">0.01 (&#x02212;0.28 to 0.31)</td><td align="left" valign="top" rowspan="1" colspan="1">0.93</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.04 (&#x02212;0.28 to 0.20)</td><td align="left" valign="top" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">0.12 (&#x02212;0.78 to 1.03)</td><td align="left" valign="top" rowspan="1" colspan="1">0.78</td><td align="left" valign="top" rowspan="1" colspan="1">0.42 (&#x02212;0.30 to 1.14)</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MDA</td><td align="left" valign="top" rowspan="1" colspan="1">0.05 (&#x02212;0.32 to 0.42)</td><td align="left" valign="top" rowspan="1" colspan="1">0.80</td><td align="left" valign="top" rowspan="1" colspan="1">0.36 (0.10 to 0.63)</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ox-GS<break/><bold>Pre-morning to next-morning</bold><xref rid="TFN6" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.21 (&#x02212;0.69 to 1.11)</td><td align="left" valign="top" rowspan="1" colspan="1">0.64</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.36 (&#x02212;1.08 to 0.37)</td><td align="left" valign="top" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mutagenicity</td><td align="left" valign="top" rowspan="1" colspan="1">0.05 (&#x02212;0.30 to 0.40)</td><td align="left" valign="top" rowspan="1" colspan="1">0.77</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.27 (&#x02212;0.53, to 0.01)</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8-isoprostane</td><td align="left" valign="top" rowspan="1" colspan="1">0.50 (&#x02212;0.75 to 1.74)</td><td align="left" valign="top" rowspan="1" colspan="1">0.42</td><td align="left" valign="top" rowspan="1" colspan="1">0.20 (&#x02212;0.83 to 1.23)</td><td align="left" valign="top" rowspan="1" colspan="1">0.70</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MDA</td><td align="left" valign="top" rowspan="1" colspan="1">0.26 (&#x02212;0.24 to 0.76)</td><td align="left" valign="top" rowspan="1" colspan="1">0.30</td><td align="left" valign="top" rowspan="1" colspan="1">0.31 (&#x02212;0.09 to 0.70)</td><td align="left" valign="top" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ox-GS</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.62 (&#x02212;1.31 to 0.08)</td><td align="left" valign="top" rowspan="1" colspan="1">0.08</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.32 (&#x02212;0.92 to 0.27)</td><td align="left" valign="top" rowspan="1" colspan="1">0.27</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><label>*</label><p id="P64">Cross-shift changes were defined as log (post-shift or next-morning) versus log (pre-shift) and results were backlog-transformed. MDA, malondialdehyde; Ox-GS, oxidised guanine species; WLFFs, wildland firefighters.</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float"><caption><title>Key messages</title></caption><sec id="S18"><title>What is already known about this subject?</title><list list-type="bullet" id="L1"><list-item><p id="P65">Exposure to biomass smoke emissions due to incomplete combustion has been associated with systemic health effects among exposed individuals, including wildland firefighters.</p></list-item><list-item><p id="P66">However, limitations exist regarding geographical location and the assessement of the potential impact of occupational exposure to wildland fire smoke on wildland firefighters&#x02019; health.</p></list-item></list></sec><sec id="S19"><title>What are the new findings?</title><list list-type="bullet" id="L2"><list-item><p id="P67">Our study is the first to evaluate the effect of fire smoke exposure on systemic health status in wildland firefighters who worked at prescribed burns in the Midwest.</p></list-item><list-item><p id="P68">Compared with the other regions, wildland firefighters in this study had a higher urinary mutagenicity and oxidative stress presumably due to repeated exposure to elevated levels of fire smoke emissions during prescribed burns compared with a previous study done in the Southeast.</p></list-item></list></sec><sec id="S20"><title>How might this impact on policy or clinical practice in the foreseeable future?</title><list list-type="bullet" id="L3"><list-item><p id="P69">The results of this study suggest that wildland firefighters might need a suitable respiratory protection against peak smoke exposure situations as they consistently work under high physical exertion and breathing rate.</p></list-item><list-item><p id="P70">This is especially the case given that firefighters typically approach a smouldering fire more than they do a flaming fire (for safety reasons), but the mutagenicity emission factor of smouldering biomass is ~10 times greater than that of flaming biomass.</p></list-item></list></sec></boxed-text></floats-group></article>